Utility of LymphoTrack for clonality testing in formalinfixed, paraffin-embedded tissue: integrated panel- and specimen-level comparison with fragment analysis
Journal of Pathology and Translational Medicine · 13.11.2026
DOI: 10.4132/jptm.2026.10.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pathology and Translational Medicine, online erschienen am 13.11.2026. Verfasst von Ki-Chang Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Seoul National University Hospital, Seoul, Korea.
Abstract (Originalsprache)
Background
Next-generation sequencing-based clonality assays provide sequence-level resolution but remain vulnerable to panel-specific failure in formalin-fixed, paraffin-embedded (FFPE) tissue. We evaluated LymphoTrack performance and integrated multi-panel interpretation.
Methods
Seventeen FFPE specimens from 16 patients underwent 51 immunoglobulin heavy-chain (IGH) and 12 T-cell receptor (TCR) panel runs. Results were classified as Positive, Negative, or Fail and compared with lineage-level fragment-analysis interpretations. Panels targeting each lineage were integrated into specimen-level interpretations. Quality-control metrics associated with panel failure were explored.
Results
Among 51 IGH panel runs, 37 (72.5%) were concordant, four (7.8%) discordant, and 10 (19.6%) Fail; all Fail results occurred in FR1 or FR2. IGH specimen-level agreement was 16/17 (94.1%; 95% confidence interval [CI], 73.0% to 99.0%). LymphoTrack classified four IGH specimens as monoclonal and 13 as polyclonal, including six based on incomplete panel coverage. One such specimen (FR1/FR2 Fail and FR3 Negative) was discordant with monoclonal fragment analysis. TCR specimen-level agreement was 5/6 (83.3%; 95% CI, 43.6% to 97.0%). In the discordant TCR specimen, T-cell receptor gamma (TRG) fragment analysis was oligoclonal, whereas both LymphoTrack TRG and T-cell receptor beta were Positive. A post-polymerase chain reaction library concentration threshold of ≤4.5 ng/μL identified all Fail panels but had limited specificity (58.5%) and precision (31.3%).
Conclusions
LymphoTrack showed high specimen-level agreement with fragment analysis despite panel-specific technical vulnerability in FFPE tissue. Partial panel failure had asymmetric implications: a Positive panel preserved a monoclonal interpretation, whereas polyclonal results with incomplete panel coverage remained vulnerable to discordance. Reporting incomplete panel coverage may help communicate this limitation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Seoul National University Hospital, Seoul, Korea.
- Field Application Specialist Team, Dow Biomedica Inc., Seoul, Korea.
- Cancer Research Institute, Seoul National University, Seoul, Korea.
- Department of Pathology, Seoul National University Hospital, Seoul, Korea. sgsong.path@gmail.com.
- Department of Pathology, Seoul National University Hospital, Seoul, Korea. ykjeon@snu.ac.kr.
- Cancer Research Institute, Seoul National University, Seoul, Korea. ykjeon@snu.ac.kr.
Zitieren
APA
Lee, K. C., Kim, H. A., Koh, J., Bae, J. M., Lee, C., Song, S. G., & Jeon, Y. K. (2026). Utility of LymphoTrack for clonality testing in formalinfixed, paraffin-embedded tissue: integrated panel- and specimen-level comparison with fragment analysis. Journal of Pathology and Translational Medicine. https://doi.org/10.4132/jptm.2026.10.02
Vancouver
Lee KC, Kim HA, Koh J, Bae JM, Lee C, Song SG, et al. Utility of LymphoTrack for clonality testing in formalinfixed, paraffin-embedded tissue: integrated panel- and specimen-level comparison with fragment analysis. Journal of Pathology and Translational Medicine. 2026. doi:10.4132/jptm.2026.10.02
BibTeX
@article{Lee2026,
author = {Lee, Ki-Chang and Kim, Hyun-A and Koh, Jiwon and Bae, Jeong Mo and Lee, Cheol and Song, Seung Geun and Jeon, Yoon Kyung},
title = {Utility of LymphoTrack for clonality testing in formalinfixed, paraffin-embedded tissue: integrated panel- and specimen-level comparison with fragment analysis},
journal = {Journal of Pathology and Translational Medicine},
year = {2026},
doi = {10.4132/jptm.2026.10.02}
}
EUVIMED